Ejiao Act of 2023
Latest Action
Referred to the Subcommittee on Trade.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Ejiao Act of 2023 is a bill introduced in the 118th Congress, originating in the House of Representatives. The bill is related to the health policy area but lacks an official summary and full text publicly available. As of the latest update on December 17, 2024, the bill was referred to the Subcommittee on Trade. The bill status is marked as Failed / Expired, indicating it did not advance to become law during the session. Due to the absence of detailed content, the specific provisions, objectives, and mechanisms of the bill remain unclear.
The Ejiao Act of 2023 was a health-related bill referred to a trade subcommittee but ultimately failed to progress, with no detailed public information on its content or impact.
- The bill is titled Ejiao Act of 2023 and was introduced in the House during the 118th Congress.
- It is categorized under the health policy area but lacks an official summary and full text.
- The latest legislative action was referral to the Subcommittee on Trade on December 17, 2024.
- The bill status is Failed / Expired, indicating it did not pass or advance further.
['Not determinable from available data due to lack of bill content and summary.']
["Lack of publicly available full text and official summary limits transparency and understanding of the bill's scope and implications.", 'Without detailed provisions, it is not possible to assess implementation challenges, costs, or oversight mechanisms.', 'Referral to a trade subcommittee suggests potential intersections between health and trade policy, which may involve complex jurisdictional considerations.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Trade. The absence of further legislative action and its status as Failed / Expired indicate it did not gain sufficient support or priority to advance. The lack of a summary or text limits insight into the bill's intended policy goals or alignment with broader legislative priorities.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential overlap or conflict between health and trade policy areas due to referral to the Subcommittee on Trade.', 'Possible missed opportunities for stakeholder engagement and public input given the lack of transparency.', 'Uncertain regulatory or economic impacts on industries related to health and trade due to unknown bill provisions.']
The absence of an official summary and full bill text significantly limits transparency and public understanding of the Ejiao Act of 2023. This lack of information hinders effective oversight and informed debate. The referral to a trade subcommittee despite classification under health suggests a cross-policy dimension that requires clear articulation in future legislative efforts. Improved documentation and timely publication of bill details are essential for government transparency and accountability.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.